Patient Registry Started for the Medical Breakthrough Treatment of Vagus Nerve Stimulation



In an effort to further understand why vagus nerve stimulation therapy is more effective than anitidepressants with patients who suffer from chrnic depression, the manufacturer of the vagus nerve stimulator, Cyberonics, Inc., announced the launch of the first treatment resistant depression(TRD) patient registry. This registry that will help the medical communitys understanding of TRD, and determine which pateints are most appropriate for this procedure. I think that the data produced from the registry will significantly help psychiatrists further understanding how this vagus nerve stimulation is effective.

Click here to read the full article


Related Articles:

Patient Registry Started for the Medical Breakthrough Treatment of Vagus Nerve Stimulation

Vagus Nerve Stimulation and Depression Conference

The Top Ten Things You Need to Know About Vagus Nerve Stimulation for Depression

How Does Vagus Nerve Stimulation for Treating Depression Work

Insurance Reimbursement for Vagus Nerve Stimulation and Depression

Top Fifteen Definitions for Understanding Vagus Nerve Stimulation and Depression

Efficacy and Safety of Vagus Nerve Stimulation for Depression Published in Journal

Insurance Plans are Reimbursing Vagus Nerve Stimulation Therapy for Depression

US News and World Report Discusses Vagus Nerve Stimulation and Depression

Depression Symptoms: Disease or State of Mind Learn How Vagus Nerve Stimulation Can Help

Insurance Companies are Beginning to Reimburse for Vagus Nerve Stimulation Therapy for Depression

May 6th deadline: Medicares final decision to cover vagus nerve stimulation therapy for depression




Home

Mental Health Management

Link Exchange




Use of this site is subject to our Disclaimer.